Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data
Journal of Antimicrobial Chemotherapy · 01.12.2023 · 78 (12) · 2933-2937
DOI: 10.1093/jac/dkad333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 27.10.2023. Verfasst von Yuto Yamada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu 501-1194, Japan. Hauptthemen laut MEDLINE: Vancomycin, Acute Kidney Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
Although use of AUC-guided vancomycin dosing was recommended in the revised 2020 consensus guideline, collection of multiple vancomycin serum samples to calculate AUC may cause clinical complications. AUC calculated from trough-only data (one-point AUC-guided dosing) has not been sufficiently validated. The aim of the present study was to compare the incidence of nephrotoxicity following the change from trough-guided to one-point AUC-guided dosing.
Methods
We conducted a single-centre, prospective cohort study to compare the incidence of nephrotoxicity between a trough-guided dosing group and one-point AUC-guided dosing group.
Results
One-point AUC-guided dosing significantly decreased the incidence of acute kidney injury (AKI) compared with trough-guided dosing (2.8% versus 17.4%, P = 0.002). Further, Kaplan–Meier plots for cumulative incidence of the AKI-free rate indicated that the onset of AKI was significantly longer in the one-point AUC-guided dosing group than in trough-guided dosing (HR, 6.5; 95% CI, 1.5–27.4; P = 0.011). Moreover, multivariate Cox proportional hazard analysis indicated that implementation of one-point AUC-guided dosing was a significant protective factor against the incidence of AKI (age-adjusted HR, 0.164; 95% CI, 0.04–0.69; P = 0.014).
Conclusions
Compared with trough concentration-guided dosing, AUC-guided dosing using one-point sampling markedly reduced the incidence of AKI, without additional serum sampling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu 501-1194, Japan.
- Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.
ORCID-Profile: Yuto Yamada, Takashi Niwa, Ryo Kobayashi, Akio Suzuki
Zitieren
APA
Yamada, Y., Niwa, T., Ono, Y., Yamada, S., Niwa, K., Yasue, M., Yamamoto, T., Sumi, K., Otsubo, M., Kobayashi, R., & Suzuki, A. (2023). Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data. Journal of Antimicrobial Chemotherapy, 78(12), 2933-2937. https://doi.org/10.1093/jac/dkad333
Vancouver
Yamada Y, Niwa T, Ono Y, Yamada S, Niwa K, Yasue M, et al. Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data. Journal of Antimicrobial Chemotherapy. 2023;78(12):2933-2937. doi:10.1093/jac/dkad333
BibTeX
@article{Yamada2023,
author = {Yamada, Yuto and Niwa, Takashi and Ono, Yurie and Yamada, Shoya and Niwa, Kyoko and Yasue, Moeka and Yamamoto, Taishi and Sumi, Kazuyuki and Otsubo, Manami and Kobayashi, Ryo and Suzuki, Akio},
title = {Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
volume = {78},
number = {12},
pages = {2933--2937},
doi = {10.1093/jac/dkad333}
}
EUVIMED